The synthetic pharmaceutical
manufacturing plants produce a number of
finished products and intermediaries in batch
processes in various combinations and production
campaigns. They also use a
wide variety of chemical processes
during the production of
different molecules , like sulphonation,
friedel crafts reaction, nitrification,
extraction, purification and packaging.
Because of the low yield in each step, the
pharma effluents are known to contain high
concentration of organic compounds (COD) and
total solids, and solvent.
Besides variety and high concentration, the
effluent are also
inconsistent, and vary widely depending on
the product manufactured, materials used
and the processing details .
For the reasons mentioned above, the
Pharmaceutical effluents are very
challenging to treat. The conventional
activated sludge is not sophisticated enough to
treat such a widely varying concentration
of chemicals. Of the several
chemicals used there is
eminent possibility that some are strongly
inhibiting also. The presence of
pharmaceutical compounds in surface waters is an
emerging environmental issue.
Almost All the industries have
effluent treatment plants. All of them
have gone through several modifications
adding one or more equipments till there is no
more to add… and yet the desired results
generally, have not been
achieved.
Industries starts wondering
what is the path forward?
The silver bullet
solution is SBR+RO. Sequential Batch
Reactor + Reverse
osmosis.
This system is low in capital
and operating cost.
The reliability of this
system will far exceed that of conventional
activated sludge and Disc membrane system
|
